Incidence and long-term outcomes of surgically treated childhood hepatic malignancies in Finland.

Aged Child Child, Preschool Finland / epidemiology Hepatoblastoma / drug therapy Humans Incidence Infant Liver Neoplasms / epidemiology Liver Transplantation Treatment Outcome
children hepatoblastoma hepatocellular carcinoma liver cancer liver transplantation

Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
02 2020
Historique:
received: 23 03 2019
revised: 06 06 2019
accepted: 24 07 2019
pubmed: 28 7 2019
medline: 15 5 2021
entrez: 28 7 2019
Statut: ppublish

Résumé

To analyse incidence, treatment and outcomes of paediatric liver malignancies in Finland during 1987-2017. Medical records and national cancer registry data of 47 children with liver malignancies were reviewed. Survival was calculated with the Kaplan-Meier method. During follow-up, liver malignancy incidence remained stable at 1.1:10 Outcomes for PRETEXT I-III hepatoblastoma and un-metastasized hepatocellular carcinoma were encouraging. Adverse effects of chemotherapy significantly contributed to mortality.

Identifiants

DOI: 10.1111/apa.14952 PMID: 31350767
pubmed: 31350767
doi: 10.1111/apa.14952
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

404-414

Informations de copyright

©2019 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Références

Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer 2012; 59: 776-779.
Meyers RL, Maibach R, Hiyama E, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. Lancet Oncol 2017; 18: 122-131.
McAteer JP, Goldin AB, Healey PJ, Gow KW. Surgical treatment of primary liver tumors in children: outcomes analysis of resection and transplantation in the SEER database. Pediatr Transplant 2013; 17: 744-750.
Baumann U, Adam R, Duvoux C, et al. Survival of children after liver transplantation for hepatocellular carcinoma. Liver Transpl 2018; 24: 246-255.
Lau CS, Mahendraraj K, Chamberlain RS. Hepatocellular carcinoma in the pediatric population: a population based clinical outcomes study involving 257 patients from the surveillance, epidemiology, and end result (SEER) database (1973-2011). HPB Surg 2015; 2015: 670728.
Allan BJ, Wang B, Davis JS, et al. A review of 218 pediatric cases of hepatocellular carcinoma. J Pediatr Surg 2014; 49: 166-171.
Techavichit P, Masand PM, Himes RW, et al. Undifferentiated embryonal sarcoma of the liver (UESL): a single-center experience and review of the literature. J Pediatr Hematol Oncol 2016; 38: 261-268.
Schmid I, Häberle B, Albert MH, et al. Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatr Blood Cancer 2012; 58: 539-544.
Zsiros J, Maibach R, Shafford E, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 2010; 28: 2584-2590.
Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007; 37: 123-132.
Karasawa T, Steyger PS. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 2015; 237: 219-227.
Landier W, Armenian S, Bhatia S. Late effects of childhood cancer and its treatment. Pediatr Clin North Am 2015; 62: 275-300.
Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008; 112: 416-432.
Pukkala E. Biopanks and registers in epidemiologic research on cancer. Methods Mol Biol 2011; 675: 127-164.
Mazzaferro V, Regalia E, Docri R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer 2004; 40: 411-421.
Zsiros J, Brugieres L, Brock P, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol 2013; 14: 834-842.
Official Statistics of Finland (OSF): Births [e-publication]. ISSN = 1798-2413. Helsinki: Statistics Finland [referred: 28.7.2018]. Access method: http://www.stat.fi/til/synt/index_en.html
Gatta G, Ferrari A, Stiller CA, et al. Embryonal cancers in Europe. Eur J Cancer 2012; 48: 1425-1433.
Malek MM, Shah SR, Atri P, et al. Review of outcomes of primary liver cancers in children; our institutional experience with resection and transplantation. Surgery 2010; 148: 778-782.
Pham TA, Gallo AM, Concepcion W, Esquivel CO, Bonham CA. Effect of liver transplant on long-term disease-free survival in children with hepatoblastoma and hepatocellular Cancer. JAMA Surg 2015; 150: 1150-1158.
Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): and epidemiological study. Lancet 2004; 364: 2097-2105.
Stiller CA, Pritchard J, Stelariova-Foucher E. Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 2115-2123.
de Ville de Goyet J, Meyers RL, Tiao GM, Morland B. Beyond the Milan criteria for liver transplantation in children with hepatic tumours. Lancet Gastroenterol Hepatol 2017; 2: 456-462.
Kohorst MA, Warad DM, Matsumoto JM, et al. Management of pediatric hepatocellular carcinoma: a multimodal approach. Pediatr Transplant 2017; 21.
Armenian S, Bhatia S. Predicting and preventing anthracycline-related cardiotoxicity. Am Soc Clin Oncol Educ Book 2018; 38: 3-12.
Liang F, Zhang S, Xue H, Chen Q. Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies. BMC Cancer 2017; 17: 871.
Brock PR, Maibach R, Childs M, et al. Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med 2018; 378: 2376-2385.

Auteurs

Toivo Tiusanen (T)

Pediatric Liver and Gut Research Group, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
ORCID: 0000-0002-5740-0721

Maria Hukkinen (M)

Pediatric Liver and Gut Research Group, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Section of Pediatric Surgery, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Outi Leskinen (O)

HUS Medical Imaging Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Tea Soini (T)

Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Jukka A Kanerva (JA)

Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Timo Jahnukainen (T)

Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Department of Pediatric Nephrology and Transplantation, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Heikki Mäkisalo (H)

Department of Liver and Transplantation Surgery, University Hospital, University of Helsinki, Helsinki, Finland.

Markku Heikinheimo (M)

Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Department of Pediatrics, Washington University, St. Louis, MO, USA.

Mikko P Pakarinen (MP)

Pediatric Liver and Gut Research Group, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Pediatric Research Center, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Section of Pediatric Surgery, Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Régions géographiques › Europe › Pays nordiques et scandinaves › Finlande › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs complexes et mixtes › Hépatoblastome › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Incidence › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation de tissu › Transplantation hépatique › Incidence and long-term outcomes of surgically...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Incidence and long-term outcomes of surgically...